Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
Smith+Nephew (LSE:SN, NYSE:SNN) has signed a co-marketing agreement with JointVue for its OrthoSonic™ 3D Surgery Planning Technology, the only ultrasound device currently on the market to deliver 3D preoperative planning. This technology will be used with Smith+Nephew's CORI◊ Surgical System for robotic-assisted knee arthroplasty, allowing surgeons to create personalized surgical plans.
The combination offers an ideal solution for Ambulatory Surgery Centers (ASCs) where OR space is JointVue's technology provides a radiation-free, automated planning tool that generates a 3D plan within minutes, guiding surgeons to tailor procedures uniquely to each patient. This partnership expands the imaging modalities available to Smith+Nephew customers for pre-op robotic planning, potentially improving patient satisfaction and operating room efficiency.
Smith+Nephew (LSE:SN, NYSE:SNN) ha firmato un accordo di co-marketing con JointVue per la sua OrthoSonic™ 3D Surgery Planning Technology, l'unico dispositivo ad ultrasuoni attualmente disponibile sul mercato che offre pianificazione preoperatoria in 3D. Questa tecnologia sarà utilizzata con il CORI◊ Surgical System di Smith+Nephew per l'arthroplastica del ginocchio assistita da robot, consentendo ai chirurghi di creare piani chirurgici personalizzati.
La combinazione rappresenta una soluzione ideale per i Centri di Chirurgia Ambulatoriale (ASC) dove lo spazio in sala operatoria è limitato. La tecnologia di JointVue fornisce uno strumento di pianificazione automatizzato e senza radiazioni che genera un piano 3D in pochi minuti, guidando i chirurghi nella personalizzazione delle procedure per ogni singolo paziente. Questa partnership amplia le modalità di imaging disponibili per i clienti di Smith+Nephew per la pianificazione robotica preoperatoria, migliorando potenzialmente la soddisfazione dei pazienti e l'efficienza in sala operatoria.
Smith+Nephew (LSE:SN, NYSE:SNN) ha firmado un acuerdo de co-marketing con JointVue para su OrthoSonic™ 3D Surgery Planning Technology, el único dispositivo de ultrasonido disponible en el mercado que ofrece planificación preoperatoria en 3D. Esta tecnología se utilizará junto con el CORI◊ Surgical System de Smith+Nephew para la artroplastia de rodilla asistida por robot, permitiendo a los cirujanos crear planes quirúrgicos personalizados.
La combinación ofrece una solución ideal para los Centros de Cirugía Ambulatoria (ASC), donde el espacio en el quirófano es limitado. La tecnología de JointVue proporciona una herramienta de planificación automatizada y libre de radiación que genera un plan en 3D en minutos, guiando a los cirujanos para adaptar los procedimientos de manera única a cada paciente. Esta asociación amplía las modalidades de imagen disponibles para los clientes de Smith+Nephew para la planificación robótica preoperatoria, mejorando potencialmente la satisfacción del paciente y la eficiencia en el quirófano.
Smith+Nephew (LSE:SN, NYSE:SNN)는 OrthoSonic™ 3D Surgery Planning Technology에 대해 JointVue와 공동 마케팅 계약을 체결했습니다. 이는 현재 시장에서 유일하게 3D 수술 계획을 제공하는 초음파 장치입니다. 이 기술은 Smith+Nephew의 CORI◊ Surgical System과 함께 사용되어 로봇 보조 무릎 관절 치환 수술을 지원하며, 외과의사들이 개인화된 수술 계획을 수립할 수 있도록 합니다.
이 조합은 제한된 운영실 공간이 있는 외래 수술 센터(ASC)에 이상적인 솔루션을 제공합니다. JointVue의 기술은 방사선이 없는 자동 계획 도구를 제공하여 몇 분 안에 3D 계획을 생성하고, 외과의사들이 각 환자에게 맞춤형으로 절차를 조정하도록 안내합니다. 이 파트너십은 Smith+Nephew 고객을 위한 수술 전 로봇 계획에 사용할 수 있는 이미징 모달리티를 확장하여 환자 만족도와 수술실 효율성을 향상시킬 수 있습니다.
Smith+Nephew (LSE:SN, NYSE:SNN) a signé un accord de co-marketing avec JointVue pour sa OrthoSonic™ 3D Surgery Planning Technology, le seul dispositif à ultrasons actuellement sur le marché capable de fournir une planification préopératoire en 3D. Cette technologie sera utilisée avec le CORI◊ Surgical System de Smith+Nephew pour l'arthroplastie du genou assistée par robot, permettant aux chirurgiens de créer des plans chirurgicaux personnalisés.
La combinaison offre une solution idéale pour les Centres de Chirurgie Ambulatoriale (ASC) où l'espace en salle d'opération est limité. La technologie de JointVue fournit un outil de planification automatisé et sans radiation qui génère un plan 3D en quelques minutes, guidant les chirurgiens pour adapter les procédures de manière unique à chaque patient. Ce partenariat élargit les modalités d'imagerie disponibles pour les clients de Smith+Nephew pour la planification robotique préopératoire, améliorant potentiellement la satisfaction des patients et l'efficacité des salles d'opération.
Smith+Nephew (LSE:SN, NYSE:SNN) hat eine Co-Marketing-Vereinbarung mit JointVue für die OrthoSonic™ 3D Surgery Planning Technology unterzeichnet, das einzige Ultraschallgerät auf dem Markt, das eine 3D präoperative Planung bietet. Diese Technologie wird zusammen mit dem CORI◊ Surgical System von Smith+Nephew für die robotergestützte Kniegelenksarthroplastik verwendet, wodurch Chirurgen personalisierte chirurgische Pläne erstellen können.
Die Kombination bietet eine ideale Lösung für ambulante Operationszentren (ASC), wo der Operationssaal begrenzt ist. Die Technologie von JointVue bietet ein strahlungsfreies, automatisiertes Planungstool, das innerhalb von Minuten einen 3D-Plan erstellt und Chirurgen anleitet, um die Verfahren individuell auf jeden Patienten zuzuschneiden. Diese Partnerschaft erweitert die verfügbaren Bildgebungsmodalitäten für die Kunden von Smith+Nephew zur robotergestützten präoperativen Planung und könnte die Patientenzufriedenheit sowie die Effizienz im Operationssaal verbessern.
- Partnership with JointVue expands Smith+Nephew's preoperative planning capabilities
- Radiation-free ultrasound technology offers quick 3D planning within minutes
- Solution is ideal for space- Ambulatory Surgery Centers (ASCs)
- Potential to improve patient satisfaction and operating room efficiency
- Enhances personalization of knee arthroplasty procedures
- None.
Insights
Key benefits include:
- Just-in-time implant delivery, reducing inventory and costs
- Ideal for space-constrained Ambulatory Surgery Centers
- Radiation-free 3D imaging in minutes at the clinic
- Automated planning for personalized procedures
While this partnership strengthens Smith+Nephew's position in the growing robotics-assisted surgery market, the immediate financial impact may be However, long-term potential exists for increased market share and revenue growth, especially in the ASC segment. Investors should monitor adoption rates and any impact on Smith+Nephew's competitive positioning in the orthopaedic robotics space.
Patented technology further personalizes total knee arthroplasty for surgeons and patients
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D Surgery Planning Technology – the only ultrasound device currently on the market to deliver 3D preoperative planning. JointVue’s technology allows surgeons using Smith+Nephew’s CORI◊ Surgical System for robotic-assisted knee arthroplasty to create a personalized surgical plan, which may provide opportunities to improve patient satisfaction and operating room efficiency.
Pre-operative surgical planning provides the surgeon with information about the patient's anatomy to help the surgeon determine the preferred implants before the surgery begins. This foresight helps to enable just-in-time delivery of implants and instruments, helping to conserve space and reduce both operating room (OR) time and sterilization costs. The combination of JointVue’s OrthoSonic technology with Smith+Nephew’s CORI Surgical System, known for its small footprint and scalability, offers an ideal solution for Ambulatory Surgery Centers (ASCs) where OR space is limited.
The CORI Surgical System stands out in the market with its image-agnostic registration capabilities, offering both image-free and MRI-powered options for pre-operative planning. Now, with the exclusive adoption of JointVue’s OrthoSonic 3D Surgery Planning Technology for Smith+Nephew implants, surgeons have access to an additional procedural solution that utilizes ultrasound to generate a 3D plan within minutes. This radiation-free, automated planning tool guides surgeons to tailor the procedure uniquely to each patient.
“JointVue’s OrthoSonic technology allows surgeons and patients to get a 3D look inside their knee at the clinic in minutes without radiation - replacing a trip to the imaging center as they get ready for surgery,” said Steven MacDonald, MD, and CEO of JointVue. “The 3D image and automated planning tool helps orthopaedic surgeons personalize the procedure uniquely for each patient.”
As the field of robotic-assisted knee surgery continues to evolve, the demand for solutions that cater to diverse patient profiles, coupled with advanced planning and execution tools, is paramount in personalizing surgery. Robotic-assisted surgery can significantly enhance accuracy and reproducibility, potentially leading to improved patient outcomes compared to conventional techniques.1-3
“The addition of JointVue’s technology further expands the imaging modalities available to Smith+Nephew customers for pre-op robotic planning,” said Mayank Shandil, Global SVP of Recon and Robotics Marketing for Smith+Nephew. “The combination of JointVue with the CORI Surgical System for robotic-assisted knee replacement provides a personalized solution for surgeons and patients and is a perfect fit for the growing ASC market.”
To learn more about the CORI Surgical System and Smith+Nephew’s digital surgery applications across a range of joint arthroplasty indications, please visit https://www.smith-nephew.com/en/health-care-professionals/products/orthopaedics/cori
- ends –
Media Enquiries
Dave Snyder +1 (978) 749-1440
Smith+Nephew david.snyder@smith-nephew.com
References
- Matsumoto T, Nakano N, Hayashi S, et al. Prosthetic orientation, limb alignment, and soft tissue balance with bi-cruciate stabilized total knee arthroplasty: a comparison between the handheld robot and conventional techniques. International Orthopaedics 2023;47(6):1473-80. doi: 10.1007/s00264-023-05737-6
- Crizer MP, Haffar A, Battenberg A, et al. Robotic Assistance in Unicompartmental Knee Arthroplasty Results in Superior Early Functional Recovery and Is More Likely to Meet Patient Expectations. Advances in Orthopedics 2021;2021 doi: 10.1155/2021/4770960
- Negrín R, Duboy J, Iñiguez M, et al. Robotic-assisted vs conventional surgery in medial unicompartmental knee arthroplasty: a clinical and radiological study. Knee Surg Relat Res 2021;33(1):5. doi: 10.1186/s43019-021-00087-2 [published Online First: 2021/02/14]
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 18,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.
◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.
FAQ
What is the new partnership between Smith+Nephew (SNN) and JointVue?
How does JointVue's OrthoSonic technology benefit surgeons using Smith+Nephew's CORI Surgical System?
What advantages does the Smith+Nephew (SNN) and JointVue partnership offer for Ambulatory Surgery Centers?
How does the new JointVue technology integrate with Smith+Nephew's (SNN) existing CORI Surgical System?
